HIV, Africa and Donald Trump
Trump's Aid Cuts Stop South African HIV Vaccine Trials in Their Tracks
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work. The first round of vaccines she and her colleagues made in Johannesburg had produced an immune response in rabbits,
In Africa, a U.S. funding loss will be critical to HIV programs in countries like Uganda, Mozambique and Tanzania.
Majola is one of millions of patients in South Africa affected by President Donald Trump’s global foreign aid freeze, raising worries about HIV patients defaulting on treatment, infection rates ...
Majola is one of millions of patients in South Africa affected by U.S. President Donald Trump’s global foreign aid freeze, raising worries about HIV patients defaulting on treatment, infection ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback